Asanka Sudeshini Hewage
Overview
Explore the profile of Asanka Sudeshini Hewage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
11
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samarasinghe S, Hewage A, Siriwardana R, Tennekoon K, Niriella M, De Silva S, et al.
BMC Gastroenterol
. 2025 Mar;
25(1):151.
PMID: 40065199
Background: Single nucleotide polymorphisms (SNPs) in patatin-like phospholipase domain-containing protein 3 (PNPLA3), transmembrane 6 superfamily member 2 (TM6SF2) and membrane bound O-acyltransferase domain containing 7 (MBOAT7) genes were reported to...
2.
Samarasinghe S, Sundralingam T, Hewage A, de Silva K, Tennekoon K
Growth Horm IGF Res
. 2021 Dec;
62:101443.
PMID: 34971854
Objective: To identify and characterize a novel deletion at the LHX4 gene locus in a proband with growth hormone deficiency (GHD). Methods: Long range polymerase chain reaction (PCR) amplification was...
3.
Sundralingam T, Tennekoon K, de Silva S, De Silva S, Hewage A
Growth Horm IGF Res
. 2017 Sep;
36:22-29.
PMID: 28910730
Objective: Genetic alterations in GH1 and GHRHR genes are known to cause isolated growth hormone deficiency (IGHD). Of these, GHRHR codon 72 mutation has been reported to be highly prevalent...
4.
Wickramage I, Tennekoon K, Ariyaratne M, Hewage A, Sundralingam T
Breast Cancer (Dove Med Press)
. 2017 Mar;
9:111-120.
PMID: 28293118
Introduction And Aims: Tamoxifen is an adjuvant drug effective in treating hormone receptor - positive breast cancer. However, 30%-50% of patients relapse and many develop adverse effects, such as hot...